ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$4.41
Tradestie Score
57
Market Cap
$202.58M
Revenue Growth
-0.1%
Analyst Upside
+130.9%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$40.55
|
$824.20M | - | 64 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.46
|
$821.84M | - | 58 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$56.55
|
$800.41M | - | 56 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$14.23
|
$799.70M | - | 42 | Compare |
|
KURA
Kura Oncology, Inc.
|
$10.65
|
$798.53M | - | 63 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$11.29
|
$791.82M | - | 46 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$8.27
|
$757.72M | - | 46 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$28.93
|
$748.90M | - | 48 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$23.34
|
$718.62M | - | 61 | Compare |
More ACRS Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry